CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
During the quarter, US formulations revenue increased by 13.5 per cent YoY to Rs. 4,072 crore
The observations are of procedural in nature and will be responded to within the stipulated time
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The plant is yet to start commercial operations
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
Subscribe To Our Newsletter & Stay Updated